Fromm MF - Search Results

1

MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine.

Drescher S, Schaeffeler E, Hitzl M, Hofmann U, Schwab M, Brinkmann U, Eichelbaum M, Fromm MF. Drescher S, et al. Among authors: fromm mf. Br J Clin Pharmacol. 2002 May;53(5):526-34. doi: 10.1046/j.1365-2125.2002.01591.x. Br J Clin Pharmacol. 2002. PMID: 11994059 Free PMC article. Clinical Trial.

2

Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans.

Fromm MF, Hofmann U, Griese EU, Mikus G. Fromm MF, et al. Clin Pharmacol Ther. 1995 Oct;58(4):374-82. doi: 10.1016/0009-9236(95)90049-7. Clin Pharmacol Ther. 1995. PMID: 7586928 Clinical Trial.

3

Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its phase I and phase II metabolites.

Fromm MF, Botsch S, Heinkele G, Evers J, Kroemer HK. Fromm MF, et al. Eur J Clin Pharmacol. 1995;48(3-4):279-83. doi: 10.1007/BF00198312. Eur J Clin Pharmacol. 1995. PMID: 7589055 Clinical Trial.

4

Simultaneous determination of dihydrocodeine and dihydromorphine in serum by gas chromatography-tandem mass spectrometry.

Hofmann U, Fromm MF, Johnson S, Mikus G. Hofmann U, et al. Among authors: fromm mf. J Chromatogr B Biomed Appl. 1995 Jan 6;663(1):59-65. doi: 10.1016/0378-4347(94)00423-3. J Chromatogr B Biomed Appl. 1995. PMID: 7704214

5

An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy.

Kroemer HK, Fromm MF, Bühl K, Terefe H, Blaschke G, Eichelbaum M. Kroemer HK, et al. Among authors: fromm mf. Circulation. 1994 May;89(5):2396-400. doi: 10.1161/01.cir.89.5.2396. Circulation. 1994. PMID: 7910120 Clinical Trial.

6

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.

Fromm MF, Busse D, Kroemer HK, Eichelbaum M. Fromm MF, et al. Hepatology. 1996 Oct;24(4):796-801. doi: 10.1002/hep.510240407. Hepatology. 1996. PMID: 8855178

7

Stereoselectivity in drug metabolism and action: effects of enzyme inhibition and induction.

Kroemer HK, Fromm MF, Eichelbaum M. Kroemer HK, et al. Among authors: fromm mf. Ther Drug Monit. 1996 Aug;18(4):388-92. doi: 10.1097/00007691-199608000-00013. Ther Drug Monit. 1996. PMID: 8857556

8

Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue.

Kivistö KT, Bookjans G, Fromm MF, Griese EU, Münzel P, Kroemer HK. Kivistö KT, et al. Among authors: fromm mf. Br J Clin Pharmacol. 1996 Sep;42(3):387-9. doi: 10.1046/j.1365-2125.1996.42615.x. Br J Clin Pharmacol. 1996. PMID: 8877031 Free PMC article.

9

Loss of analgesic effect of morphine due to coadministration of rifampin.

Fromm MF, Eckhardt K, Li S, Schänzle G, Hofmann U, Mikus G, Eichelbaum M. Fromm MF, et al. Pain. 1997 Aug;72(1-2):261-7. doi: 10.1016/s0304-3959(97)00044-4. Pain. 1997. PMID: 9272811 Clinical Trial.

10

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

Kim RB, Fromm MF, Wandel C, Leake B, Wood AJ, Roden DM, Wilkinson GR. Kim RB, et al. Among authors: fromm mf. J Clin Invest. 1998 Jan 15;101(2):289-94. doi: 10.1172/JCI1269. J Clin Invest. 1998. PMID: 9435299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters